Intensity Therapeutics (INTS) Proxy Filing summary

Executive summary

• Special Meeting scheduled for October 22, 2025, to address key corporate actions.

• Shareholders are encouraged to vote online or virtually at the meeting.

Voting matters and shareholder proposals

• Proposal to approve a reverse stock split of common stock at a ratio between one-for-five and one-for-thirty, with the exact ratio determined by the board.

• Proposal to approve adjournment of the meeting if more time is needed to solicit votes for the reverse stock split.

• Board recommends voting in favor of both proposals.

Shareholder rights and capital structure

• Reverse stock split will not reduce the authorized number of shares of common stock.